首页> 外国专利> PDGF AND VEGF BINDING APTAMERS AND THEIR USE IN TREATING PDGF AND VEGF MEDIATED CONDITIONS

PDGF AND VEGF BINDING APTAMERS AND THEIR USE IN TREATING PDGF AND VEGF MEDIATED CONDITIONS

机译:PDGF和VEGF结合的适体及其在治疗PDGF和VEGF介导的条件中的用途

摘要

To provide aptamers useful for preventing and treating disorders in which PDGF and/or VEGF has been implicated.SOLUTION: An aptamer comprises a sequence: 5'-NZVSLnS'V'ZACNNmGCGZZZAZAGCG-3' (SEQ ID NO: 500), wherein V is selected from an A, C or G; V' is selected from a C, G or Z, wherein V' is complementary to V; S and S' are independently selected from a C or G, wherein S and S' are complementary to each other; each N is independently selected from any naturally occurring or modified nucleotide; each Z is independently selected from a modified pyrimidine; L is selected from any naturally occurring or modified nucleotide, a hydrocarbon linker, a polyethylene glycol linker or a spacer selected from combinations thereof; n is 0 to 20; and m is 0 to 20; and wherein one or more nucleotide insertions are optionally included, as needed.SELECTED DRAWING: Figure 1-1
机译:为了提供可用于预防和治疗涉及PDGF和/或VEGF的疾病的适体。解决方案:适体包含序列:5'-NZVSLnS'V'ZACNNmGCGZZZAZAGCG-3'(SEQ ID NO:500),其中V是选自A,C或G; V′选自C,G或Z,其中V′与V互补。 S和S'独立地选自C或G,其中S和S'彼此互补;每个N独立地选自任何天然存在或修饰的核苷酸;每个Z独立地选自修饰的嘧啶; L选自任何天然存在或修饰的核苷酸,烃连接基,聚乙二醇连接基或选自其组合的间隔基; n为0至20; m为0至20;并根据需要选择包含一个或多个核苷酸插入。图1-1

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号